- This event has passed.
Feb 11 @ 12:00 pm - 1:00 pm PST
Research Lunch-N-Learn: CALM-2
Bring your lunch, we’ll supply an informative presentation and cookies.
Learn about the current trial focusing on Hypertension and the CALM-2 Mobuis HD device. Current enrollment is open to qualifying participants.
• MobiusHD is a unique device targeting baroreceptors in the carotid sinus
• CALM-FIM study showed endovascular baroreceptor amplification (EVBA) with the MobiusHD device significantly lowered blood pressure in resistant hypertensive patients patients with resistant HTN
• The CALM-2 randomized, sham-controlled trial is designed to comprehensively assess the safety and efficacy of the MobiusHD device in patients with resistant hypertension
All health practitioners & administrators are welcome to join.
RSVP’s not necessary but appreciated at: RenownCME@renown.org